Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2

Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2

Coronavirus disease 2019 (COVID-19) caused by 'Severe Acute Respiratory Syndrome Coronavirus-2' (SARS-CoV-2) infection emerged in Wuhan, a city of China, and spread to the entire planet in early 2020. The virus enters the respiratory tract cells and other tissues via ACE2 receptors. Approx...

Full description

Bibliographic Details
Main Author:	Burak Pamukçu
Format:	Article
Language:	English
Published:	KARE Publishing 2020-10-01
Series:	Anatolian Journal of Cardiology
Subjects:	covid-19 sars-cov-2 inflammation thrombosis clinical outcomes d-dimer disseminated intravascular coagulation antithrombotic therapy heparin low molecular weight heparins oral anticoagulants
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-56727

Similar Items

Bioequivalence of a biosimilar enoxaparin (Cloti‐Xa™) and its innovator (Clexane®): A single‐dose, randomized, double‐blind, two‐period, two‐treatment, two‐sequence, crossover, balanced study in healthy human subjects
by: Sumit Saxena, et al.
Published: (2022-08-01)

Heparin and its derivatives in the treatment of arterial thrombosis: a review
by: M. Dvorak, et al.
Published: (2010-11-01)

The Coagulopathy Bleeding in Disseminated Intravascular Coagulation. Therapy by Heparin and Treatment Plasmapheresis
by: Kurgan M., et al.
Published: (2015-12-01)

Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome
by: A. D. Makatsariya, et al.
Published: (2020-07-01)

Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy
by: Ze Zhang, et al.
Published: (2023-06-01)

A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19
by: Ying-feng Lu, et al.
Published: (2020-11-01)

Efficacy and safety of heparin for sepsis-induced disseminated intravascular coagulation (HepSIC): study protocol for a multicenter randomized controlled trial
by: Yini Sun, et al.
Published: (2024-01-01)

Management Strategies in Septic Coagulopathy: A Review of the Current Literature
by: Piotr F. Czempik, et al.
Published: (2023-01-01)

Effects of thrombomodulin alfa on hemostatic parameters in disseminated intravascular coagulation: Post hoc analysis of a phase 3 randomized controlled trial
by: Takashi Ito, et al.
Published: (2020-10-01)

Cancer-Associated Thrombosis: A New Light on an Old Story
by: Sidrah Shah, et al.
Published: (2021-05-01)

Autoimmune Heparin-Induced Thrombocytopenia
by: Theodore E. Warkentin
Published: (2023-11-01)

Anticoagulación y sepsis, la oportunidad para un nuevo uso de la heparina?
by: Fabián Jaimes, et al.
Published: (2006-03-01)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
by: Isabelle Mahé, et al.
Published: (2019-07-01)

Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
by: Agnes Y.Y. Lee
Published: (2024-02-01)

Proposal of the Definition for COVID-19-Associated Coagulopathy
by: Toshiaki Iba, et al.
Published: (2021-01-01)

Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
by: Jia-Jia Huang, et al.
Published: (2023-05-01)

Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
by: Sophie Susen, et al.
Published: (2020-06-01)

In vivo antithrombotic properties of a heparin from the oocyte test cells of the sea squirt Styela plicata(Chordata-Tunicata)
by: L. Cardilo-Reis, et al.
Published: (2006-11-01)

Update on Anticoagulation Strategies in Patients with ECMO—A Narrative Review
by: Ján Šoltés, et al.
Published: (2023-09-01)

Updates in Anticoagulation Therapy Monitoring
by: Hannah L. McRae, et al.
Published: (2021-03-01)

CHEMICAL MODIFICATION OF SURGICAL SUTURE MATERIAL TO PREVENT ARTERIAL THROMBOSIS
by: T. N. Akentyeva, et al.
Published: (2014-11-01)

Safety of low-dose anticoagulation in extracorporeal membrane oxygenation using the Permanent Life Support System: a retrospective observational study
by: Kyungsub Song, et al.
Published: (2023-07-01)

Confusing combination of thrombocytopenia and thrombosis after heparin therapy in a patient with cardiac leiomyosarcoma; a nephrologist viewpoint
by: Ardalan Mohammad-Reza
Published: (2014-04-01)

Heparins Sourced From Bovine and Porcine Mucosa Gain Exclusive Monographs in the Brazilian Pharmacopeia
by: Eduardo Vilanova, et al.
Published: (2019-02-01)

Concurrent arterial and venous thrombosis in a patient with catastrophic antiphospholipid syndrome
by: Muhammad Shoaib Khan, et al.
Published: (2021-07-01)

Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
by: Sven R. Olson, et al.
Published: (2019-07-01)

Cancer thrombosis: Narrative review
by: Pritesh Naresh Munot, et al.
Published: (2020-01-01)

ANTITHROMBOTIC THERAPY IN CANCER PATIENTS
by: A. V. Vorobev, et al.
Published: (2016-06-01)

DOES HEPARIN HAVE AN ESSENTIAL ROLE IN THE TREATMENT OF THE COVID-19 PANDEMIC? A REVIEW
by: Luma Al-Obaidy, et al.
Published: (2021-03-01)

Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry
by: Zygimantas Zaboras, et al.
Published: (2024-01-01)

Hypercoagulopathy in Overweight and Obese COVID-19 Patients: A Single-Center Case Series
by: Sarfraz Azza, et al.
Published: (2021-11-01)

The application of anticoagulant therapy to sepsis
by: Jecko Thachil, et al.
Published: (2017-05-01)

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era
by: Kayla Torppey, et al.
Published: (2023-10-01)

Osteoporosis and antithrombotic therapy
by: N. V. Brailova, et al.
Published: (2021-06-01)

An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations
by: Amin Islam, et al.
Published: (2021-08-01)

Coagulation disorders in SARS-CoV-2 infection
by: Romeo Gabriel Mihaila, et al.
Published: (2020-09-01)

Cost-effective treatment for deep-vein thrombosis in rural tertiary care hospital
by: Arunkumar Arasappa, et al.
Published: (2022-01-01)

Spontaneous Breast Haematoma after Heparin Anticoagulation
by: Imran Yaseen Gani, et al.
Published: (2020-06-01)

Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy
by: Vincenzo Russo, et al.
Published: (2023-09-01)

Current Recommendations for the Management of Cancer-Associated Venous Thromboembolism
by: Makó Katalin
Published: (2021-06-01)